Seeking Alpha


Send Message
View as an RSS Feed
Latest  |  Highest rated
  • The FDA has approved J&J's (JNJ) Invokana drug for treating type 2 diabetes in a new way by causing the body to excrete blood sugar via the urine rather than affecting the supply or use of insulin. The agency said J&J must carry out five post-marketing studies to determine whether the drug increases the risks of strokes, heart attacks and other side effects. Invokana is forecast to generate sales of $667M by 2016. [View news story]
    This great news for a lot people that have to take insulin. Blessing in happing.
    Apr 1, 2013. 04:58 AM | Likes Like |Link to Comment
  • Sprint (S) says it isn't planning any immediate takeover of Clearwire (CLWR), tabling any talk of a deal for at least 6-8 months until the Softbank deal closes. Shares of Clearwire jumped 16% today on speculation of an imminent takeover, and have skyrocketed 78% over the last two trading days the previous week. Despite the fervor, a deal between the two is speculative at best. S doesn’t need to own CLWR because it already has access to its spectrum, and its very expensive to boot. [View news story]
    go Sprint******
    Oct 16, 2012. 08:54 AM | Likes Like |Link to Comment